slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 26,611-26,640
Pages 2,019
Rows per page 30
Component
26,611-26,640 of 60,557
08
The slide uses a 'company favorable' assumption model to demonstrate that even under best-case scenarios, the core business is declining.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
09
The slide uses a table to highlight specific growth projections and includes a testimonial quote to undermine the company's narrative.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
10
The slide uses a quote from a former employee and a direct excerpt from Google's policy to support its bearish thesis.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
03
The slide uses a forensic accounting approach to compare claimed vs. actual user data.iQIYI, Inc. (IQ) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
04
The slide uses a combination of a quantitative table to show data discrepancy and a narrative argument to suggest fraudulent activity (click farms) based on geographic anomalies.iQIYI, Inc. (IQ) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
05
The table highlights specific low-population regions appearing in top-10 rankings, which the author argues is statistically improbable.iQIYI, Inc. (IQ) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
211
The slide uses a table to contrast the solubility of different diazoxide forms to undermine the company's rationale for their specific formulation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
214
The slide uses molecular weight calculations to expose that DCCR is simply a salt form of diazoxide, implying the price premium is unjustified.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
220
The slide uses a quote from a trial investigator to expose a potential safety oversight in study design.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
111
The slide uses a Q&A format to highlight rumors of financial incentives influencing hospital usage of TransMedics devices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
176
The slide uses a table from a JAMA Surgery paper to highlight the mean donor age in the trial (45.9 years) as evidence of selection bias.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
211
The slide uses a Q&A format to highlight the 'unusual' nature of the credentialing process, followed by a direct citation of the AOPO manual to suggest a violation of standard protocols.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
04
The slide uses highly aggressive, loaded language typical of short-seller activist reports.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Introduction to Twist Bioscience's issues1 hit
25
The slide uses aggressive, emotive language ('dumpster fire', 'spectacle', 'circus') typical of activist short-seller reports.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy1 hit
32
The slide uses aggressive, inflammatory language ('junkie', 'crackhead', 'toilet paper') to characterize the company's financial strategy.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy1 hit
39
The slide uses a DNA ladder diagram to illustrate the concept of an oligo as a single-stranded fragment.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
99
The slide uses a Q&A format to build a narrative of financial failure based on operational inefficiency.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
110
The slide uses a red box to highlight the 'Gross margin' row and a red arrow to draw attention to the trend, framing the discrepancy as a potential accounting issue.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
111
The slide uses a red circle to highlight the 2018 data point as a focal point for the argument.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
116
The slide uses a financial table to highlight the discrepancy between R&D spending and revenue compared to COGS.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
117
The slide uses red circles and lines to draw attention to specific data points in the table that support the argument of suspicious R&D spending.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
124
The slide uses a combination of a bar chart and a financial table to highlight the discrepancy in Capex spending patterns.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
130
The slide uses a rhetorical question to frame the discrepancy in capex as a potential red flag.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
136
The slide uses a table from a 10K filing and a direct quote to expose a discrepancy in corporate messaging.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
142
Uses a combination of earnings call transcript excerpts and a table from a 10K filing to point out the discrepancy.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
184
Uses LinkedIn Insights data and 10K filings to highlight a contradiction between company narrative and operational reality.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
185
The slide uses a red box to highlight the specific data point (Sales -60%) that contradicts the company's narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
205
The slide uses a Q&A format to validate the thesis that Twist faces an existential threat from new market entrants.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
223
The slide uses a combination of regulatory filing text and a registry search report to build a case of potential impropriety.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
234
The slide uses a red box to highlight Paladin Capital Group in the table.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit